Durvalumab plus platinum–etoposide versus platinum–etoposide in first-line treatment of extensive-stage small-cell lung cancer (CASPIAN): a randomised, controlled, open-label, phase 3 trial Luis Paz‐Ares , Mikhail Dvorkin , Yuanbin Chen +97 more 2019 The Lancet 2014 citations